Technical Analysis for AGN - Allergan, Inc.

Grade Last Price % Change Price Change
grade B 173.6 0.64% 1.10
AGN closed up 0.64 percent on Friday, October 18, 2019, on 1.29 times normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Earnings due: Nov 5

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Up
See historical AGN trend table...

Date Alert Name Type % Chg
NR7 Range Contraction 33.98%
Multiple of Ten Bearish Other 33.98%
Overbought Stochastic Strength 33.98%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 32.71%
Stochastic Reached Overbought Strength 32.71%
Multiple of Ten Bullish Other 32.71%
Weak + Overbought Other 32.71%
Inside Day Range Contraction 32.71%
Overbought Stochastic Strength 32.71%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 32.70%

Older signals for AGN ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Allergan, Inc. operates as a multi-specialty healthcare company primarily in the United States, Europe, Latin America, and the Asia Pacific. The company discovers, develops, and commercializes pharmaceutical, biological, medical device, and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatological, breast aesthetics, urological, and other specialty markets. It operates in two segments, Specialty Pharmaceuticals and Medical Devices. The Specialty Pharmaceuticals segment produces a range of pharmaceutical products, including ophthalmic products for dry eye, glaucoma, inflammation, infection, allergy, and retinal disease; Botox for certain therapeutic and aesthetic indications; skin care products for acne, psoriasis, eyelash growth, and other prescription and over-the-counter skin care products; and urologics products. The Medical Devices segment offers a range of medical devices, such as breast implants for augmentation, revision, and reconstructive surgery, as well as tissue expanders; and facial aesthetics products. The company sells its products to drug wholesalers, independent and chain drug stores, pharmacies, commercial optical chains, opticians, mass merchandisers, food stores, hospitals, group purchasing organizations, integrated direct hospital networks, ambulatory surgery centers, government purchasing agencies, and medical practitioners. It focuses on eye care professionals, neurologists, physiatrists, dermatologists, plastic and reconstructive surgeons, aesthetic specialty physicians, bariatric surgeons, urologists, and general practitioners. The company has collaboration agreements with Molecular Partners AG; Spectrum Pharmaceuticals, Inc.; and Serenity Pharmaceuticals, LLC. Allergan, Inc. was founded in 1948 and is headquartered in Irvine, California.
Medicine Medical Specialties Life Sciences Pharmaceutical Surgery Pharmaceutical Products Inflammation Infection Psoriasis Medical Devices Glaucoma Acne Allergy Medical Device Skin Care Products Ophthalmic Products Breast Implant Breast Implants Over The Counter Products Retinal Disease Allergan Bausch Health Food Stores
Is AGN a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 190.36
52 Week Low 114.27
Average Volume 2,679,021
200-Day Moving Average 150.4267
50-Day Moving Average 164.346
20-Day Moving Average 168.2655
10-Day Moving Average 169.486
Average True Range 1.6883
ADX 32.72
+DI 40.1064
-DI 11.2048
Chandelier Exit (Long, 3 ATRs ) 169.5551
Chandelier Exit (Short, 3 ATRs ) 169.9849
Upper Bollinger Band 172.4229
Lower Bollinger Band 164.1081
Percent B (%b) 1.14
BandWidth 4.941476
MACD Line 2.0152
MACD Signal Line 1.618
MACD Histogram 0.3972
Fundamentals Value
Market Cap 58.03 Billion
Num Shares 334 Million
EPS 32.82
Price-to-Earnings (P/E) Ratio 5.29
Price-to-Sales 3.91
Price-to-Book 0.84
PEG Ratio 0.97
Dividend 2.80
Dividend Yield 1.61%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 176.56
Resistance 3 (R3) 176.57 175.59 176.06
Resistance 2 (R2) 175.59 174.84 175.59 175.90
Resistance 1 (R1) 174.60 174.38 175.10 174.59 175.73
Pivot Point 173.62 173.62 173.87 173.62 173.62
Support 1 (S1) 172.63 172.87 173.13 172.62 171.47
Support 2 (S2) 171.65 172.41 171.65 171.30
Support 3 (S3) 170.66 171.65 171.14
Support 4 (S4) 170.65